Concepedia

Bingying Luo

BL

Statistics

Publications

3

Citations

169

H-Index

3

Active since

2021

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Tianjin Medical University

Bingying Luo is an author at Tianjin Medical University Cancer Institute and Hospital specializing in checkpoint inhibitor immunostimulation, medicine, and combination immunotherapy.

ORCID

Publications per year

2021–2024

3

Publications

3

Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma

Yudong Su, Bingying Luo, Yao Lu et al. · Clinical Cancer Research · 2021 · 145 citations · Full text

, , +17

Using a Gene Network of Pyroptosis to Quantify the Responses to Immunotherapy and Prognosis for Neuroblastoma Patients

Bingying Luo, Limin Wang, Weijing Gao et al. · Frontiers in Immunology · 2022 · 13 citations · Full text

, , +17

StereoSiTE: a framework to spatially and quantitatively profile the cellular neighborhood organized iTME

Xing Liu, Chi Qu, Chuandong Liu et al. · GigaScience · 2024 · 11 citations · Full text

, , +17

1–3 of 3